Cargando...
mTOR signaling: new networks for ALL
Compared with rapamycin, mammalian target of rapamycin (mTOR) dual inhibitors have shown improved ability to kill acute lymphocytic leukemia (ALL) cells in preclinical models. In this issue of Blood, Yun et al have identified novel signaling pathways downstream of mTOR that are disrupted by dual inh...
Guardado en:
| Publicado en: | Blood |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Hematology
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4891950/ https://ncbi.nlm.nih.gov/pubmed/27257176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-03-703199 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|